Cannabidiol, cognition and schizophrenia: a narrative review
Schizophrenia is a serious mental disorder affecting about 1% of the population. It is characterised by multiple symptoms which are mostly responsive to treatment with antipsychotic medications. Cognitive impairment is regarded as a core feature of illness which is mostly poorly responsive to treatm...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2024-02-01
|
Series: | Exploration of Medicine |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/em/Article/1001204 |